| Literature DB >> 11792833 |
Deborah Thompson1, Csilla I Szabo, Jon Mangion, Rogier A Oldenburg, Fabrice Odefrey, Sheila Seal, Rita Barfoot, Karin Kroeze-Jansema, Dawn Teare, Nazneen Rahman, Hélène Renard, Graham Mann, John L Hopper, Saundra S Buys, Irene L Andrulis, Ruby Senie, Mary B Daly, Dee West, Elaine A Ostrander, Ken Offit, Tamar Peretz, Ana Osorio, J Benitez, Katherine L Nathanson, Olga M Sinilnikova, Edith Olàh, Yves-Jean Bignon, Pablo Ruiz, Michael D Badzioch, Hans F A Vasen, Andrew P Futreal, Catherine M Phelan, Steven A Narod, Henry T Lynch, Bruce A J Ponder, Ros A Eeles, Hanne Meijers-Heijboer, Dominique Stoppa-Lyonnet, Fergus J Couch, Diana M Eccles, D Gareth Evans, Jenny Chang-Claude, Gilbert Lenoir, Barbara L Weber, Peter Devilee, Douglas F Easton, David E Goldgar, Michael R Stratton.
Abstract
The known susceptibility genes for breast cancer, including BRCA1 and BRCA2, only account for a minority of the familial aggregation of the disease. A recent study of 77 multiple case breast cancer families from Scandinavia found evidence of linkage between the disease and polymorphic markers on chromosome 13q21. We have evaluated the contribution of this candidate "BRCA3" locus to breast cancer susceptibility in 128 high-risk breast cancer families of Western European ancestry with no identified BRCA1 or BRCA2 mutations. No evidence of linkage was found. The estimated proportion (alpha) of families linked to a susceptibility locus at D13S1308, the location estimated by Kainu et al. [(2000) Proc. Natl. Acad. Sci. USA 97, 9603-9608], was 0 (upper 95% confidence limit 0.13). Adjustment for possible bias due to selection of families on the basis of linkage evidence at BRCA2 did not materially alter this result (alpha = 0, upper 95% confidence limit 0.18). The proportion of linked families reported by Kainu et al. (0.65) is excluded with a high degree of confidence in our dataset [heterogeneity logarithm of odds (HLOD) at alpha = 0.65 was -11.0]. We conclude that, if a susceptibility gene does exist at this locus, it can only account for a small proportion of non-BRCA1/2 families with multiple cases of early-onset breast cancer.Entities:
Mesh:
Year: 2002 PMID: 11792833 PMCID: PMC117390 DOI: 10.1073/pnas.012584499
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205